Korsana Biosciences, Inc. (KRSA)
NASDAQ · Manufacturing · Pharmaceutical preparations
KRSA price, last 12 months
Key stats
- Previous close
- $33.27
- Open
- $33.56
- Day range
- $32.50 – $35.85
- 52-week range
- $21.00 – $39.41
- Volume
- 313.8K
- Avg volume (20 days)
- 201.3K
- Market cap
- $1.4B
Performance
Technicals and fundamentals
About Korsana Biosciences, Inc.
Korsana Biosciences Inc is a biopharmaceutical company developing therapeutics to treat neurodegenerative diseases beginning with Alzheimer's disease (AD. The company's flagship product candidate, KRSA-028, is an anti-amyloid beta antibody that combines the proprietary Therapeutic Targeting (THETA) platform with well-validated aspects from other anti-Ab products that have achieved regulatory approval or are in late-stage clinical trials.
- Sector
- Manufacturing
- Industry
- Pharmaceutical preparations
- Listed on
- NASDAQ
- Market cap
- $1.4B